Oxford BioDynamics Financials

Oxford BioDynamics Stock Summary

Oxford BioDynamics competes with Protalix Biotherapeutics, Seres Therapeutics, Cidara Therapeutics, and Immunitybio. Oxford BioDynamics Plc, a biotechnology company, discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and internationally. Oxford BioDynamics Plc was incorporated in 2007 and is headquartered in Oxford, the United Kingdom. Oxford Biodynamics operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 44 people.

Oxford BioDynamics Key Financial Ratios

There are many critical financial ratios that Oxford BioDynamics' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Oxford BioDynamics Plc reports annually and quarterly.

Oxford Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Oxford BioDynamics's current stock value. Our valuation model uses many indicators to compare Oxford BioDynamics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Oxford BioDynamics competition to find correlations between indicators driving Oxford BioDynamics's intrinsic value. More Info.Oxford BioDynamics Plc is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Oxford BioDynamics' earnings, one of the primary drivers of an investment's value.

Oxford BioDynamics Plc Systematic Risk

Along with financial statement analysis, the daily predictive indicators of Oxford BioDynamics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Oxford BioDynamics Plc. We use our internally-developed statistical techniques to arrive at the intrinsic value of Oxford BioDynamics Plc based on widely used predictive technical indicators. In general, we focus on analyzing Oxford Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Oxford BioDynamics's daily price indicators and compare them against related drivers.

When running Oxford BioDynamics' price analysis, check to measure Oxford BioDynamics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oxford BioDynamics is operating at the current time. Most of Oxford BioDynamics' value examination focuses on studying past and present price action to predict the probability of Oxford BioDynamics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oxford BioDynamics' price. Additionally, you may evaluate how the addition of Oxford BioDynamics to your portfolios can decrease your overall portfolio volatility.